Navigation Links
Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
Date:4/9/2008

ATLANTA, April 9, 2008 /PRNewswire-USNewswire/ -- Dutch biotechnology company Crucell N.V., the Aeras Global TB Vaccine Foundation and the South African Tuberculosis Vaccine Initiative (SATVI) present a progress update and immunology data from a Phase I Ad35 tuberculosis vaccine study at the biennial "Tuberculosis Vaccines for the World" conference (Atlanta, Georgia, April 9 to 11) today. The study, conducted in Worcester, South Africa and launched in May 2007, is the second phase I study in a current series of three and has revealed promising results.

Highest CD8 immune responses ever in a TB vaccine study

Preliminary data show both critical arms of the cellular immune system, CD4 and CD8 immune T-cells were induced and that in those participants who responded, CD8 immune responses are considerably higher than has ever previously been seen in a TB vaccine study.

The trial of AERAS-402/Crucell Ad35, which began in May 2007, is being conducted as a double-blind, randomized, placebo-controlled dose escalation study in four groups of healthy adults vaccinated at birth with BCG (Bacille Calmette-Guerin) vaccine. A total of 40 healthy adult volunteers are enrolled.

"While preliminary, these results are promising. We are pleased that Crucell's technologies are playing a key role in the search and development of a much-needed TB vaccine," said Dr. Jaap Goudsmit, Chief Scientific Officer at Crucell. "We highly value the collaboration with Aeras and SATVI on this important mission."

Third key clinical phase I study in progress

Aeras and Crucell began jointly developing this vaccine candidate in 2004 using Crucell's AdVac(R) vaccine technology and PER.C6(R) manufacturing technology. A first Phase I clinical trial launched in October 2006 in Kansas, USA indicated that the vaccine candidate is safe in healthy adults in the US. The results of a second study, launched in May 2007, are presented in Atlanta at the "TB
'/>"/>

SOURCE Aeras Global TB Vaccine Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
2. Artists for a New South Africa Will be Shaking The Blues at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb Mo, Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles
3. Grammy Winner Marc Cohn to Perform for African AIDS Organization at Carolina HopeFest
4. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
5. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
6. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
7. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
8. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
9. Tampax and Always Launch Protecting Futures Program Dedicated to Helping African Girls Stay in School
10. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
11. Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014  Decision Resources Group ... the United States will increase to a ... be primarily driven by expansion in the large direct ... devices will be increasingly adopted due to the advantages ... Other key findings from Decision Resources Group,s coverage ...
(Date:12/19/2014)... , Dec. 18, 2014 Since last ... the site now known as the leading online black ... seen explosive growth in its offering of drugs and ... Alliance show the takedowns did succeed in lowering the ... last review of the markets in August. But some ...
(Date:12/17/2014)... SAN DIEGO , Dec. 17, 2014 ... PHIA) and Volcano Corporation (NASDAQ: VOLC ), a ... applications, today announced that they have entered into a definitive ... tender offer to acquire all of the issued and outstanding ... total equity purchase price of USD 1 billion (approx. EUR ...
Breaking Medicine Technology:U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8
... July 5, 2011 Allure Medical Spa released an ... and to help them visualize potential outcomes. "Many of ... the newest treatments," explains board certified cosmetic surgeon, Dr. ... digital resource in the palm of their hands that ...
... 5, 2011 Dr. Michael Lowenstein, co-medical director of ... detoxification under deep sedation, is expressing grave concern over ... alarming rise in number of individuals seeking treatment for ... The new national analysis from the U.S. ...
Cached Medicine Technology:Cosmetic Surgery iPhone App Teaches and Amuses 2Waismann Method Medical Director Cautions of Increasing Numbers of Opioid Addicts 2
(Date:12/19/2014)... (PRWEB) December 20, 2014 The Medspa ... new injectable filler from respected cosmetic brand Juvéderm. Voluma ... naturally with age. The Medspa at Hendrick is pleased ... in skin care technology to its clients. , Voluma ... to be FDA-approved to treat the mid-face and cheek ...
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- New research warns parents that ... lives at risk. Nearly half of teen drivers killed in ... were at least 11 years old and often lacked important safety ... Eighty-two percent of teen drivers killed in crashes were in cars ... to 10 years old, 31 percent were in cars 11 to ...
(Date:12/19/2014)... All children should have their eyesight checked between the ... experts say. The new vision-screening guidelines for preschool-aged ... National Center for Children,s Vision Health. The panel ... for eye problems, particularly vision issues that require ... strabismus (a disorder of eye alignment). Early detection ...
(Date:12/19/2014)... 19, 2014 (HealthDay News) -- Injectable drug users who ... suicide attempt rate of other substance users, a new ... associated with the risk of suicide attempt and completed ... of Montreal, said in a university news release. "However, ... wanted to know who among substance users were actually ...
(Date:12/19/2014)... 2014 (HealthDay News) -- The cost of cancer treatment ... new study finds. Researchers examined data from 1,000 ... with colorectal or lung cancer. Of those patients, almost ... more than 100 had advanced cancer. Nearly half ... their medical bills, which was linked with a poorer ...
Breaking Medicine News(10 mins):Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Preschoolers Need Eye Screening, Experts Say 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Cancer Treatment Costs Weigh Heavily on Patients, Study Finds 2
... to Follow Dispute Resolution Process is ... the Most Expeditious Path to Final Approval -, ... DDS;,NASDAQ: DDSS) today announced that it has appealed the ... tramadol formulation to,the next supervisory level under the FDA,s ...
... -- Simcere,Pharmaceutical Group (NYSE: SCR ), a ... manufacturer of the patented,anti-cancer biotech product Endu in ... & Co.,s Fourth Investor Tour of China,being held ... 4, 2008 in Beijing,Shenzhen and Shanghai., Simcere,s ...
... New Consumer Label, WICHITA, Kan., April 1, ... that include new best practices,animal husbandry, biosecurity, and ... by VeriPrime, Inc., of Wichita, KS, at the,recommendation ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080401/AQTU070LOGO ), The Advisory Council ...
... Fork, Care and Prevention, WICHITA, Kan., April ... and higher new safety standards, including protections,against E. ... leading farmers and,ranchers behind the food safety seal, ... Citing growing consumer concern over food safety ...
... and OTTAWA, April 1, 2008 Natural,Nutrition, Inc. ... that its operating,subsidiary, InterACTIVE Nutrition, Inc. (INII) achieved ... million (CDN) in EBITDA for the,year ended December ... Nutrition, stated, "We are pleased to,report record results ...
... China,Shenghuo Pharmaceutical Holdings, Inc. (Amex: KUN ) ... the research, development, manufacture,and marketing of pharmaceutical, nutritional ... China ("PRC"), announced its financial,results for full year ... 2007 Highlights -- Net sales totaled ...
Cached Medicine News:Health News:Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy 2Health News:Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy 3Health News:Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.'s Fourth Investor Tour of China 2Health News:VeriPrime Approves New Best Practices for Beef Production 2Health News:VeriPrime Approves New Best Practices for Beef Production 3Health News:'VeriPrime Certified Safeguards' Food Safety Label Unveiled 2Health News:'VeriPrime Certified Safeguards' Food Safety Label Unveiled 3Health News:Natural Nutrition Subsidiary Reports Record Year-End Revenue and EBITDA 2Health News:China Shenghuo Reports Full Year 2007 Financial Results 2Health News:China Shenghuo Reports Full Year 2007 Financial Results 3Health News:China Shenghuo Reports Full Year 2007 Financial Results 4Health News:China Shenghuo Reports Full Year 2007 Financial Results 5Health News:China Shenghuo Reports Full Year 2007 Financial Results 6Health News:China Shenghuo Reports Full Year 2007 Financial Results 7Health News:China Shenghuo Reports Full Year 2007 Financial Results 8Health News:China Shenghuo Reports Full Year 2007 Financial Results 9Health News:China Shenghuo Reports Full Year 2007 Financial Results 10Health News:China Shenghuo Reports Full Year 2007 Financial Results 11Health News:China Shenghuo Reports Full Year 2007 Financial Results 12Health News:China Shenghuo Reports Full Year 2007 Financial Results 13
Mini-Finesse 5mm Dilating Trocar, hook electrode, two lengths, mini or basic kit....
Thoracoscopy Cannula, reusable, hook electrode, two lengths, mini or basic kit....
... Sleeve consists of a rounded ... to prevent puncture or laceration ... cavity has been entered. The ... the sleeve which enhance security ...
... three separate components: an exchange rod, a dilating ... trocar sleeve. The exchange rod is a rigid ... The dilating obturator is tapered and threaded at ... created by the 10/11mm or the 12mm ENDOPATH ...
Medicine Products: